Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Shares Up 1.4% – Should You Buy?

Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) traded up 1.4% during trading on Tuesday . The company traded as high as $17.61 and last traded at $17.39. 12,109 shares traded hands during trading, a decline of 6% from the average session volume of 12,817 shares. The stock had previously closed at $17.15.

Direxion Daily LLY Bear 1X Shares Price Performance

The company has a 50-day simple moving average of $17.53 and a 200-day simple moving average of $21.20.

Direxion Daily LLY Bear 1X Shares Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 31st. Investors of record on Tuesday, December 23rd were issued a $0.6173 dividend. This is a positive change from Direxion Daily LLY Bear 1X Shares’s previous quarterly dividend of $0.17. This represents a $2.47 dividend on an annualized basis and a dividend yield of 14.2%. The ex-dividend date of this dividend was Tuesday, December 23rd.

Institutional Investors Weigh In On Direxion Daily LLY Bear 1X Shares

A number of hedge funds have recently added to or reduced their stakes in the stock. Optiver Holding B.V. raised its stake in shares of Direxion Daily LLY Bear 1X Shares by 541.3% in the third quarter. Optiver Holding B.V. now owns 73,489 shares of the company’s stock worth $1,863,000 after acquiring an additional 62,030 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in shares of Direxion Daily LLY Bear 1X Shares during the first quarter valued at approximately $645,000. Finally, Csenge Advisory Group acquired a new stake in shares of Direxion Daily LLY Bear 1X Shares in the third quarter valued at approximately $411,000.

About Direxion Daily LLY Bear 1X Shares

Direxion Shares ETF Trust – Direxion Daily LLY Bear 1X Shares is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund employs short strategy and uses derivatives such as swaps and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization.